CD276 overexpression	Solid Tumor	CD276 overexpression	Solid Tumor	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3
CD276 overexpression	Prostate Cancer	CD276 overexpression	Prostate Cancer	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3
CD276 overexpression	Small Cell Lung Cancer	CD276 overexpression	Small Cell Lung Cancer	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3
CD276 overexpression	Non Small Cell Lung Cancer	CD276 overexpression	Non Small Cell Lung Cancer	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3
CD276 overexpression	Esophageal Squamous Cell Carcinoma	CD276 overexpression	Esophageal Squamous Cell Carcinoma	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3	DS-7300 Sensitive: C3 – Early Trials DS-7300 Sensitive : C3
CD276 underexpression + EGFR mutation	Lung Adenocarcinoma	CD276 underexpression + EGFR mutation	Lung Adenocarcinoma	EGFR inhibitor Sensitive: C3 – Early Trials EGFR inhibitor Sensitive : C3	EGFR inhibitor Sensitive: C3 – Early Trials EGFR inhibitor Sensitive : C3
CD276 expression	Clear Cell Renal Cell Carcinoma	CD276 expression	Clear Cell Renal Cell Carcinoma	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
CD276 overexpression	Non Small Cell Lung Cancer	CD276 overexpression	Non Small Cell Lung Cancer	trametinib Sensitive: D – Preclinical trametinib Sensitive : D	trametinib Sensitive: D – Preclinical trametinib Sensitive : D
CD276 expression	Head and Neck Cancer	CD276 expression	Head and Neck Cancer	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D
CD276 expression	Breast Cancer	CD276 expression	Breast Cancer	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D
CD276 overexpression	Multiple Myeloma	CD276 overexpression	Multiple Myeloma	ruxolitinib Sensitive: D – Preclinical ruxolitinib Sensitive : D	ruxolitinib Sensitive: D – Preclinical ruxolitinib Sensitive : D
CD276 expression	Acute Myelogenous Leukemia	CD276 expression	Acute Myelogenous Leukemia	s Sensitive: D – Preclinical s Sensitive : D	s Sensitive: D – Preclinical s Sensitive : D

CD276 (CD276 Molecule)

Associations(21)

Associations
(21)